Nova Biomedical Adds Sample Retain Collector to BioProfile FLEX2 Cell Culture Analyzer
By LabMedica International staff writers Posted on 25 Jan 2021 |
Image: BioProfile FLEX2 Cell Culture Analyzer (Photo courtesy of Nova Biomedical)
Nova Biomedical (Waltham, MA, USA) has added a Sample Retain Collector (SRC) for its BioProfile FLEX2 automated cell culture analyzer which measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability.
A single FLEX2 analyzer with SRC and the previously introduced Online Sampler (OLS) module provides automated sampling and analysis of these key cell culture tests from as many as 10 bioreactors. This FLEX2 automation package saves hours of time versus manual sampling, analysis, sample storage, and after-hours cell culture monitoring. The SRC automatically collects cell culture samples from the FLEX2 Online Sampler and stores them in a refrigerated environment to fulfill regulatory requirements for long-term sample retains, as well as enabling further offline testing. The SRC allows user-selectable retained sample volumes from 200uL to 50 mL at a storage temperature of 4˚C. In combination with the FLEX2 and OLS, samples from up to 10 bioreactors can be analyzed and stored by the SRC in as fast as one hour.
"We have partnered with the industry leader in liquid handling systems, Teledyne Cetac, to market this system, configured specifically to work with the FLEX2," said Matt McRae, Nova Biotechnology Product Line Manager. "The Sample Retain Collection System completes the full automation package for the FLEX2, offering the truly automated sampling, analysis, sample storage and feedback control of all measured parameters that our customers need. It also enables safe storage of retains and/or later analysis of other key cell culture attributes that today's laboratories require."
A single FLEX2 analyzer with SRC and the previously introduced Online Sampler (OLS) module provides automated sampling and analysis of these key cell culture tests from as many as 10 bioreactors. This FLEX2 automation package saves hours of time versus manual sampling, analysis, sample storage, and after-hours cell culture monitoring. The SRC automatically collects cell culture samples from the FLEX2 Online Sampler and stores them in a refrigerated environment to fulfill regulatory requirements for long-term sample retains, as well as enabling further offline testing. The SRC allows user-selectable retained sample volumes from 200uL to 50 mL at a storage temperature of 4˚C. In combination with the FLEX2 and OLS, samples from up to 10 bioreactors can be analyzed and stored by the SRC in as fast as one hour.
"We have partnered with the industry leader in liquid handling systems, Teledyne Cetac, to market this system, configured specifically to work with the FLEX2," said Matt McRae, Nova Biotechnology Product Line Manager. "The Sample Retain Collection System completes the full automation package for the FLEX2, offering the truly automated sampling, analysis, sample storage and feedback control of all measured parameters that our customers need. It also enables safe storage of retains and/or later analysis of other key cell culture attributes that today's laboratories require."
Latest Industry News
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus